Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Animal cell – per se – expressing immunoglobulin – antibody – or...
Patent
1995-03-30
1997-01-28
Loring, Susan A.
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Animal cell, per se, expressing immunoglobulin, antibody, or...
435 7021, 4351722, 435332, 530350, 5303871, 5303881, 53038825, 5303893, 530830, C12N 512, C12N 1502, C12P 2108, C07K 1618
Patent
active
055977260
ABSTRACT:
The present invention relates to a naturally occurring, minimally modified LDL antigen which is present in human atherosclerotic lesions as well as in the serum of a high percentage of patients with coronary artery disease. The invention also comprises antibodies reactive with the antigen, hybridoma cell lines that produce the antibodies of the invention, and methods for using the antibodies in the diagnosis and treatment of atherosclerotic disease.
REFERENCES:
patent: 4376110 (1983-03-01), David et al.
patent: 4632901 (1986-12-01), Valkirs et al.
patent: 4727019 (1988-02-01), Valkirs et al.
patent: 4885256 (1989-12-01), Alving et al.
patent: 4945040 (1990-07-01), Fless et al.
patent: 5110738 (1992-05-01), Takano et al.
Boyd, et al, 1989, Am. J. Pathology 135:815-825.
Chait, et al (1989), Abstract No. 0645 from the 62nd Scientific Session of the American Heart Association meeting of Nov. 13-16 in New Orleans, Louisiana.
Steinbrecher, et al, 1984, J. Lipid. Res. 25: 1109-1116.
Gonen, et al, 1987, Atherosclerosis 65:265-272.
Haberland, et al, 1988, Science 241:215-218.
Palinski, et al, Abstract No. 0055 from the 61st Scientific Session of the American Heart Association meeting of Nov. 14-17, 1988 in Washington, D.C.
Palinski, et al., Abstract No. 424 from the FASEB Journal 2(4) Mar. 15, 1988, presented at the Federation of American Societies for Experimental Biology on May 1-5, 1988 in Las Vegas, Nevada.
Kimura et al, 1986, Virchows Arch A 410:159-164.
Bauer, et al, (1982) Atherosclerosis, 44:153-160.
Palinski, et al, 1990, Artheriosclerosis 10(3): 325-335.
Palinski, et al, 1989, Proc. Natl. Acad. Sci. USA, 86:1372-1376.
Zaidi, et al, 1982, Chemical Abstracts, 96(23):19609/e.
Scopes, R. K., 1982, Protein Purification, Springer-Verlag, New York pp. 25-47.
Fisher, et al, 1986, Meth. Enzymology 128:247-262.
Hoff, H. F., et al, 1975, Arch Pathol, 99: 253-258.
Mowri, H. et al, 1988, Biochimica et Biophysica Acta, 963:208-214.
Scopes, R. K., 1982, Protein Purification, Springer-Verlag, New York pp. 25-47.
Fisher, et. al., 1986, Meth. Enzymology, 128:247-262.
Palinski et al., 1989, Proc. Natl. Acad. Sci. USA, 86:1372-1376.
Zaidi et al, 1982, Chemical Abstracts, 96(23):19609/e.
Kodama, T. et al, PNAS, 85:9238-9242, Dec. 1988.
Mowri, H. et al, Biochimica et Biophysica Acta, 963: 208-214, 1988.
Bumol Thomas F.
McEvoy Leslie M.
Eli Lilly and Company
Loring Susan A.
Norman Douglas K.
LandOfFree
Monoclonal antibodies reactive with a human atheroma associated does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibodies reactive with a human atheroma associated , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies reactive with a human atheroma associated will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-940923